Does FLORQUINITAU Cause Amyloid related imaging abnormality-oedema/effusion? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Amyloid related imaging abnormality-oedema/effusion have been filed in association with FLORQUINITAU. This represents 59.4% of all adverse event reports for FLORQUINITAU.
19
Reports of Amyloid related imaging abnormality-oedema/effusion with FLORQUINITAU
59.4%
of all FLORQUINITAU reports
0
Deaths
1
Hospitalizations
How Dangerous Is Amyloid related imaging abnormality-oedema/effusion From FLORQUINITAU?
Of the 19 reports, 1 (5.3%) required hospitalization.
Is Amyloid related imaging abnormality-oedema/effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FLORQUINITAU. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does FLORQUINITAU Cause?
Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits (19)
Superficial siderosis of central nervous system (5)
What Other Drugs Cause Amyloid related imaging abnormality-oedema/effusion?
LECANEMAB-IRMB (307)
DONANEMAB-AZBT (185)
ADUCANUMAB-AVWA (90)
ADUCANUMAB (53)
LECANEMAB (39)
FLORBETAPIR F-18 (28)
FLORBETABEN F-18 (6)